Oncologists, PCPs differ in cancer follow-up concerns

Oncologists, PCPs differ in cancer follow-up concerns
Medical oncologists and primary care physicians report different barriers/concerns in cancer follow-up care to be problematic, according to research published online May 20 in the Journal of Clinical Oncology.

(HealthDay)—Medical oncologists (MOs) and primary care physicians (PCPs) report different barriers/concerns in cancer follow-up care to be problematic, according to research published online May 20 in the Journal of Clinical Oncology.

Katherine S. Virgo, Ph.D., M.B.A., from Emory University in Atlanta, and colleagues analyzed data from a nationally representative sample of participants in the 2009 Survey of Physician Attitudes Regarding the Care of . Comparisons were made between PCP and MO responses to 10 physician-perceived care barriers/concerns.

The researchers found that, based on responses from 2,202 physicians (1,072 PCPs and 1,130 MOs), in assessing patient-related barriers, MOs were more likely than PCPs to report patient language barriers (odds ratio [OR], 1.72), insurance restrictions impeding test/treatment use (OR, 1.42), and patients requesting more aggressive testing (OR, 4.08). In assessing physician-related barriers, PCPs were more likely than MOs to report inadequate training (OR, 3.06) and ordering additional tests/treatments because of malpractice concerns (OR, 1.87). With respect to general preventive care responsibility, MOs were more likely to report uncertainty.

"MOs and PCPs perceive different cancer follow-up care barriers/concerns to be problematic," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Journal information: Journal of Clinical Oncology

Health News Copyright © 2013 HealthDay. All rights reserved.

Citation: Oncologists, PCPs differ in cancer follow-up concerns (2013, June 10) retrieved 23 April 2024 from https://medicalxpress.com/news/2013-06-oncologists-pcps-differ-cancer-follow-up.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Comprehensive discussion with docs ups cancer screening

 shares

Feedback to editors